What is CharitablePlanning.com?

CharitablePlanning.com is an online tool for planning professionals seeking to manage their research, save time and make educated decisions. In addition to a fully searchable library, useful calculations and personal file management, subscriptions include daily commentary from our team of experts on important events, as well as access to the definitive Handbook on the field of Charitable Planning.

Subscribe Now 7-day trial Learn More

Professional Subscriptions

Subscribe to get access to a full suite of professional research tools.

Subscribe Now

Daily Expert Commentary

Expert insight on the latest in charitable planning news and events.

Extensive Online Library

One of the most comprehensive online libraries available, with personal sorting and storage.

Robust Calculations

An extensive array of accurate and easy-to-use calculators.

The Handbook

The "how-tos" of charitable planning easily searchable and updated regularly.

Recent Commentary

Section 68 - An Update

Friday, January 16, 2026
Highlights Legislative

When the OBBBA was enacted this past summer, we addressed whether the "new" Section 68 applies to estates and trusts. Despite any logical arguments to the contrary, it appears that it does.

Rate for Charitable Calculations Remains Static at 4.6%

Friday, January 16, 2026
Rates / Tables / Statistics

In Rev. Rul. 2026-3, the Service announced the Section 7520 rate for February will remain static at 4.6%. The average rate for 2026 is 4.6%.

IRS Updates Applicable Federal Rates for February 2026

Thursday, January 15, 2026

The IRS has announced the Applicable Federal Rates for February 2026, including the Section 7520 rate of 4.6%.

New Life for an Old Insurance Policy (Part II)

Thursday, January 15, 2026
Historical

Donors transfer a life insurance policy to a charitable remainder unitrust and avoid income tax on the surrender of the policy. They are also able to obtain a current income tax charitable deduction, increase their retirement cash flow, and create a lasting legacy to support the treatment of brain tumors.